Evidence map›Paper›PMID 41333483›Full record

ReviewCureus2025

Schizophrenia: What We Know and What We Are Yet to Know.

David Chinonyerem, Promise T Awe, Chisom O Okaro

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David ChinonyeremHealth Sciences, University of Saskatchewan, Saskatoon, CAN.
Promise T AwePsychiatry and Behavioral Sciences, Walden University, Minneapolis, USA.
Chisom O OkaroPsychiatry and Behavioral Sciences, Federal Medical Centre, Makurdi, Makurdi, NGA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is an intricate mental disorder characterized by psychosis. The condition typically emerges during late adolescence and early adulthood, often persisting throughout a lifetime. The condition is understood to arise from a complex interplay of genetic, neurobiological, and environmental factors. This systematic review aimed to synthesize the extant knowledge state on schizophrenia through critical appraisal and integration of evidence from various domains, including neurobiology, genetics, clinical manifestations, therapeutic interventions, and environmental risk factors. We conducted an in-depth literature search on various medical databases, including PubMed, Medline, Scopus, and Google Scholar, for peer-reviewed articles focusing on schizophrenia. The study findings indicate that schizophrenia is a highly heterogeneous disorder attributable to complex interactions between neurobiological, genetic, and environmental factors, which make its diagnosis and treatment difficult. In our future studies, we intend to focus on interdisciplinary approaches and translation of molecular discoveries into clinical practice to improve diagnosis and treatment interventions, as well as reduce the schizophrenia burden.

Indexed as

antipsychotic agentsgeneticsmental health researchneurobiologypsychotic disordersschizophrenia

Identifiers

PMID41333483
PMCPMC12667222

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.